Archer Materials pivots to real-world markets, with Biochip-driven, quantitative, point-of-care potassium testing—potentially ...
2d
Abingdon Health up 14% after it wins £4.8m of US contracts for multiplex diagnostic test development
Shares in Abingdon Health PLC (AIM:ABDX) rose 14% to 8.24p after the AIM-listed rapid diagnostic test developer announced contracts worth approximately £4.8 million to develop and scale up the ...
Patent strengthens competitive position in European drug screening market and reinforces Company's European intellectual property protectionNEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results